Biological Testing TRIZ Cases

Integrated base supports precisely locate analyzer subassemblies, simplifying assembly, calibration, and maintenance while lowering cost.

Reconstructs pseudo-electropherograms from peptide-level mass spectrometry data to compare PTMs and protein aggregates with intact-mass results.

Filter light guides and a refractive reaction recess block excitation light and cancel background energy for cleaner fluorescence detection.

Reconstructs pseudo-electropherograms from peptide mass spectrometry data to reveal PTMs, aggregates, and protein heterogeneity in complex mixtures.

Combining analysis progress with operator travel time helps identify the first available analyzer across dispersed locations and reduce operator burden.

Automated mode switching lets one analyzer prepare and measure blood and body fluids accurately while reducing manual sample handling.

Extracellular vesicle protein markers enable noninvasive breast cancer subtype detection, recurrence tracking, and treatment monitoring.

Automated shaking, pipetting, and temperature control streamline western blot blocking, reagent exchange, and waste recovery across channels.

TFPI2 measurement in blood replaces invasive or radiation-based renal cancer screening with sensitive, specific early detection.

Heating mixed subject and normal blood specimens enables faster, more sensitive coagulation factor inhibitor titer measurement from reaction-curve changes.

Magnetic separation and reporter kinetic modulation cut immunoassay time to minutes while improving analyte detection sensitivity and specificity.

An integrated electroanalytical sensor combines chronoamperometry and impedance spectroscopy to measure key blood parameters from whole blood quickly.

A co-culture of cancer, stromal, and immune cells improves in vitro prediction of anticancer and immunotherapy efficacy.

Acid or alkali pretreatment frees macrolide immunosuppressants from blood binding proteins for simpler antibody testing with fewer evaporation errors.

Electrical readout in a lateral flow assay replaces faint visual lines, improving diagnostic accuracy and wireless result transmission.

Image subtraction and bleaching correction remove destaining cycles in fluorescence microscopy, speeding analysis and reducing specimen stress.

Adding purine-based interference-resistant agents to immunoassays suppresses theophylline effects and improves result accuracy.

Porous-substrate filtration and functionalized nanoparticles enable rapid bacterial counts with colorimetric or fluorescence readout and live/dead distinction.

An on-chip VRFET reference placed beside the ISFET cuts parasitic effects and drift while enabling more accurate high-sensitivity readouts.

Covalent disulfide tethering fixes portal proteins in SiNx nanopores for stable orientation, higher voltage operation, and long-range DNA sensing.

Inorganic nanoparticle barcodes raise quantum dot loading above 1% to expand spectral code capacity and simplify bead assay synthesis.

Parallel electrode-array chambers track impedance changes as immune cells attack different cancer cell types, speeding treatment selection.

Deviation-curve parameters reveal coagulation disorder causes, including DOACs effects, without slow cross-mixing tests.

Multiple tuned detection zones and an optical reader quantify antineoplastic drug contamination on site across trace to high concentrations.

A split ccGFP variant improves solubility for prolonged, low-background protein synthesis detection on microfluidic devices.

A cross-linked hydrophilic and hydrophobic membrane stack controls oxygen diffusion and path length for precise small-sample sensing.

Controlled lateral membrane flow and vertical label uptake reduce dip-time variability and improve consistency in bodily fluid analysis.

A fluorescent lateral flow strip detects HPV16 E6, E7, and E2 antibodies together, improving point-of-care sensitivity without lab complexity.

Controlled aqueous multi-phase partitioning separates cancer proteins by solvent-property differences, enabling more accurate cancer type differentiation.

By replacing endogenous CYP450 pathways with human enzymes, this model improves in vivo prediction of drug metabolism and toxicity.

Oligonucleotide-tagged antibodies and hybridizing signal complexes enable spatially resolved, amplified detection of protein interactions in tissue.

Preloaded single-use cartridges automate blood and reagent handling for faster multi-assay coagulation testing with fewer point-of-care errors.

Split fluorescent protein tags enable specific, prolonged real-time binding detection in microfluidic cell-free protein assays without wash steps.

A polynucleotide carrier and handling protein control polypeptide motion through a nanopore for accurate single-molecule current-based characterization.

Immobilized analytes are tagged with polynucleotide reporters and read by a transmembrane pore for sensitive multiplex biomarker detection.

Affinity-capture cell screening reveals target protein degradation kinetics, helping identify degraders for hard-to-drug proteins.

IGFBP-2 and IGFBP-3 expression helps distinguish transport stress from long-term welfare impairment in animal samples.

A multilayer encoded test card enables rapid multi-blood-group detection without specialized equipment, reducing manual errors in urgent or low-resource settings.

A polynucleotide carrier and handling protein control polypeptide motion through a nanopore for rapid, high-fidelity single-molecule characterization.

A metal-dye urine protein reagent uses anionic and nonionic surfactants to suppress hemoglobin interference and equalize protein reactivity.

Non-invasive cattle management data predicts postpartum metabolic disease risk before calving, avoiding blood sampling and enabling earlier intervention.

A pH 0.85-1.1 CBB reagent and 595/470 nm absorbance ratio improve protein assay sensitivity and linearity without added complexity.

PIMT selectively labels isoaspartate to create a detectable mass shift, enabling faster MS distinction from aspartate without LC.

Antibody-modified solid supports enrich digested samples before MS, enabling 0.1 pM biomarker detection for TB and HIV diagnosis.

Surface-immobilized macromolecules combine multiple functional groups to improve sensitive, specific capture of low-abundance biomolecules.

Sensor-based detection of sample container position and orientation enables adaptive user guidance, reducing blood sample errors and contamination.

Magnetic particles and fluorescent dye concentrate tagged disease components into a small region for rapid early-stage point-of-care detection.

Sequential conjugate pads with gold fentanyl antibodies and trithiocyanuric acid boost saliva test signal intensity and detect fentanyl down to 10 ng/mL.

Gold nanoparticles linked to polyclonal antibodies self-assemble on biomarker binding, creating a visible color shift for rapid low-level detection.

A helical wash flow around the analyzer probe raises shear stress and residence time, improving cleaning and reducing reagent carryover.

Synthetic polymer particles tune zeta potential and surface chemistry to limit non-specific adsorption while preserving agglutination reactivity.

Mixed-site capture and tracer antibody conjugates improve anti-drug antibody sensitivity, specificity, and quantification in patient samples.

Broad capillary immunoassay signals are quantified by whole-area integration, background subtraction, and calibration for glycoconjugates.

A T4-site binder and monomer-binding antibody form a labeled complex that detects TTR tetramers and evaluates their stability.

Alpha-emitting nanoparticles bind target molecules on a permeable membrane, enabling rapid CMOS detection without PCR amplification.